| Melissa Sandoz, PLMHP | |
|
1201 Arbor Dr, South Sioux City, NE 68776-2652 | |
| (402) 494-3337 | |
| Not Available |
| Full Name | Melissa Sandoz |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 1201 Arbor Dr, South Sioux City, Nebraska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295498483 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | 12797 (Nebraska) | Primary |
| Entity Name | Heartland Counseling Services, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033292784 PECOS PAC ID: 0749262509 Enrollment ID: O20040604000284 |
News Archive
A large-scale study examining the link between uncontrolled gout and the progression of chronic kidney disease (CKD) suggests that using an integrated disease management approach may help prevent the progression of CKD in these patients.
The Obama administration has to decide by Monday whether it wants to directly ask the Supreme Court to review the constitutionality of its signature health reform legislation. Since the 11th Circuit Court of Appeals ruled against the health law in August, the administration can either ask the full court to take another look at the case or ask the Supreme Court to review it and issue a final decision.
With research backgrounds ranging from materials engineering to molecular biophysics, seventeen leading scientists issued a statement announcing that, much as the discovery of DNA and creation of the transistor revolutionized science, there is a new scientific field on the brink of revolutionizing our approach to problems ranging from eco-safe energy to outbreaks of malaria.
CombinatoRx, Incorporated today announced that preclinical data on its discovery of novel synergistic drug combinations for the treatment of cancer will be highlighted at the 101st Annual meeting of the American Association for Cancer Research 2010, April 17-21, in Washington, DC.
MAP Pharmaceuticals, Inc. today announced the Company will present additional post-hoc analyses from the FREEDOM-301 Phase 3 trial of its investigational LEVADEX™ orally inhaled migraine therapy in two patient subpopulations that are often difficult to treat with current triptan migraine therapies: menstrual migraine and migraine with allodynia.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Melissa Sandoz, PLMHP Po Box 355, South Sioux City, NE 68776-0355 Ph: () - | Melissa Sandoz, PLMHP 1201 Arbor Dr, South Sioux City, NE 68776-2652 Ph: (402) 494-3337 |
News Archive
A large-scale study examining the link between uncontrolled gout and the progression of chronic kidney disease (CKD) suggests that using an integrated disease management approach may help prevent the progression of CKD in these patients.
The Obama administration has to decide by Monday whether it wants to directly ask the Supreme Court to review the constitutionality of its signature health reform legislation. Since the 11th Circuit Court of Appeals ruled against the health law in August, the administration can either ask the full court to take another look at the case or ask the Supreme Court to review it and issue a final decision.
With research backgrounds ranging from materials engineering to molecular biophysics, seventeen leading scientists issued a statement announcing that, much as the discovery of DNA and creation of the transistor revolutionized science, there is a new scientific field on the brink of revolutionizing our approach to problems ranging from eco-safe energy to outbreaks of malaria.
CombinatoRx, Incorporated today announced that preclinical data on its discovery of novel synergistic drug combinations for the treatment of cancer will be highlighted at the 101st Annual meeting of the American Association for Cancer Research 2010, April 17-21, in Washington, DC.
MAP Pharmaceuticals, Inc. today announced the Company will present additional post-hoc analyses from the FREEDOM-301 Phase 3 trial of its investigational LEVADEX™ orally inhaled migraine therapy in two patient subpopulations that are often difficult to treat with current triptan migraine therapies: menstrual migraine and migraine with allodynia.
› Verified 5 days ago
Robyn L Watchorn Newbrey, LMHP Counselor Medicare: Not Enrolled in Medicare Practice Location: 625 E 39th St, South Sioux City, NE 68776 Phone: 402-494-0040 Fax: 402-494-0050 | |
Lisa Bye, Counselor Medicare: Medicare Enrolled Practice Location: 1201 Arbor Drive, South Sioux City, NE 68776 Phone: 402-494-3337 Fax: 402-494-3356 | |
Carol J Maker, PLMHP Counselor Medicare: Not Enrolled in Medicare Practice Location: 625 E 39th St, South Sioux City, NE 68776 Phone: 402-494-0040 Fax: 402-494-0050 | |
Bradley A Rowe, LADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 917 W 21st St, South Sioux City, NE 68776 Phone: 402-494-3337 | |
Kelley J Polk, LIMHP,LADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 625 E 39th St, South Sioux City, NE 68776 Phone: 402-494-0040 Fax: 402-494-0050 | |
Mr. Gerald Lou Mayo Iii, MSW, PLMHP Counselor Medicare: Not Enrolled in Medicare Practice Location: 917 W 21st St, South Sioux City, NE 68776 Phone: 402-494-3337 Fax: 402-494-3356 | |
Marit Westrich, Counselor Medicare: Medicare Enrolled Practice Location: 1201 Arbor Drive, South Sioux City, NE 68776 Phone: 402-494-3337 |